Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT02713373 · COMPLETED
Trial details
- NCT number
- NCT02713373
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-05
- Primary completion
- 2020-07-28
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.